KYMR - Kymera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYMR is currently covered by 18 analysts with an average price target of $120.09. This is a potential upside of $27.5 (4.46%) from yesterday's end of day stock price of $114.96.

Kymera Therapeutics's activity chart (see below) currently has 154 price targets and 162 ratings on display. The stock rating distribution of KYMR is 97.5% BUY and 2.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.13% with an average time for these price targets to be met of 317.79 days.

Highest price target for KYMR is $180, Lowest price target is $67, average price target is $120.09.

Most recent stock forecast was given by ANDY CHEN from WOLFE. First documented stock forecast 15-Sep-2020.

Best performing analysts who are covering KYMR - Kymera Therapeutics:

Leah Rush Cann Eliana Merle Judah Frommer Andy Chen Edward Tenthoff Andrew Fein

Currently out of the existing stock ratings of KYMR, 39 are a BUY (97.5%), 1 are a HOLD (2.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Sep-2026

$180

$65.04 (56.58%)

Buy Since 26-Jun-2025

$151

$36.04 (31.35%)

$116

17 days ago
(27-Aug-2026)

11/12 (91.67%)

$30.77 (25.59%)

271

Buy Since 21-May-2021

$139

$24.04 (20.91%)

$70

1 months 7 days ago
(06-Aug-2026)

5/6 (83.33%)

$32.59 (30.63%)

549

Buy Since 16-Sep-2025

$115

$0.04 (0.03%)

$103

2 months ago
(13-Jul-2026)

3/3 (100%)

$4.6 (4.17%)

93

Buy Since 30-Jul-2025

$155

$40.04 (34.83%)

2 months 15 days ago
(29-Jun-2026)

8/9 (88.89%)

$45.68 (41.79%)

273

Show more analysts

Please expand the browser size to see the chart

What is KYMR (Kymera Therapeutics) average time for price targets to be met?

On average it took 318 days for the stock forecasts to be reached, with an average price target met ratio of 91.13%.

Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?

Andy Chen

Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?

Andy Chen works at WOLFE and has 2 price targets and 3 ratings on KYMR

Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?

Andy Chen with the highest potential upside of $65.04

Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?

Michael Schmidt with the lowest potential downside of -$62.96

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?